Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Immunotherapy Drugs market Companies

ID: MRFR/HC/5930-HCR
200 Pages
Vikita Thakur
Last Updated: February 16, 2025
Immunotherapy Drugs companies are at the forefront of cancer treatment innovation. Through research, development, and distribution, they provide groundbreaking immunotherapies, contributing to the advancement of cancer care by harnessing the body's immune system to target and eliminate cancer cells.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Immunotherapy Drugs market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)6.95%
2024 Market Size$ 71.66 Billion
2025 Market Size$ 76.64 Billion
2035 Market Size$ 150.06 Billion
Key Players
Bristol-Myers Squibb
Roche
Merck & Co.
Novartis
Amgen
Gilead Sciences
Opportunities
  • Increasing Cancer Incidence
  • Growing Investment in Cancer Research
  • Regulatory Support for Innovative Therapies

Top Industry Leaders in the Immunotherapy Drugs market

Immunotherapy Drugs Market
 

Latest Immunotherapy Drugs Companies Updates:

AstraZeneca acquires ADC Therapeutics: This $5.2 billion deal strengthens AstraZeneca's oncology pipeline, specifically expanding its presence in antibody-drug conjugates (ADCs) used in immunotherapy.

Pfizer returns Bavencio rights to Merck KGaA: While this shake-up might seem surprising, it allows Pfizer to focus on its core oncology portfolio and gain royalties on future Bavencio sales.

Merck's Keytruda expands reach: New FDA approvals for treating non-small cell lung cancer and cervical cancer solidify Keytruda's dominance in the market.

Bristol Myers Squibb's Opdivo scores big: Opdivo, another leading checkpoint inhibitor, receives FDA approval for a new combination therapy in advanced bladder cancer.

List of Immunotherapy Drugs Key companies in the market:

  • Hoffmann-La Roche AG
  • GlaxoSmithKline
  • AbbVie, Inc.
  • Amgen, Inc.
  • Merck & Co., Inc.
  • Bristol-Myers Squibb
  • Novartis International AG
  • Eli Lilly and Company
  • Johnson & Johnson
  • AstraZeneca plc